Aphria digs in over TMX dispute; inks deal for CA$92M in funding


On the same day Aphria shares slid more than 13% over delisting fears, the Leamington, Ontario-based company announced a deal to raise up to 92 million Canadian dollars ($73 million) in capital.

The new financing, announced Tuesday, came a day after the TMX Group, parent of the Toronto Stock Exchange and the TSX Venture Exchange, said that marijuana companies doing business in the United States could be delisted.

Aphria, trading on the TSE as APH, owns Liberty Health Sciences, which acquires and operates U.S.-based companies in the medical cannabis market.

In an interview with the Canadian Press, Aphria’s chief executive Vic

Aphria digs in over TMX dispute; inks deal for CA$92M in funding is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Show More

Brian Wroblewski

Brian Wroblewski has a passion for writing, travel, food and family. Since working in and around the cannabis industry since 2008, Brian brings a unique perspective to the cannabis journalism space. With a focus on emerging brands, moving the cannabis industry forward and an undeniable passion for truth in business and journalism, find some of Brian's posts across the web on digital marketing, cannabis and a variety of different topics.

Related Articles

Back to top button